_version_ 1785074830197915648
author Shide, Kotaro
Takenaka, Katsuto
Kitanaka, Akira
Numata, Akihiko
Kameda, Takuro
Yamauchi, Takuji
Inagaki, Atsushi
Mizuno, Shohei
Takami, Akiyoshi
Ito, Shinichi
Hagihara, Masao
Usuki, Kensuke
Maekawa, Takaaki
Sunami, Kazutaka
Ueda, Yasunori
Tsutsui, Miyuki
Ando, Miki
Komatsu, Norio
Ozawa, Keiya
Kurokawa, Mineo
Arai, Shunya
Mitani, Kinuko
Akashi, Koichi
Shimoda, Kazuya
author_facet Shide, Kotaro
Takenaka, Katsuto
Kitanaka, Akira
Numata, Akihiko
Kameda, Takuro
Yamauchi, Takuji
Inagaki, Atsushi
Mizuno, Shohei
Takami, Akiyoshi
Ito, Shinichi
Hagihara, Masao
Usuki, Kensuke
Maekawa, Takaaki
Sunami, Kazutaka
Ueda, Yasunori
Tsutsui, Miyuki
Ando, Miki
Komatsu, Norio
Ozawa, Keiya
Kurokawa, Mineo
Arai, Shunya
Mitani, Kinuko
Akashi, Koichi
Shimoda, Kazuya
author_sort Shide, Kotaro
collection PubMed
description
format Online
Article
Text
id pubmed-10354019
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-103540192023-07-20 Nationwide prospective survey of secondary myelofibrosis in Japan: superiority of DIPSS-plus to MYSEC-PM as a survival risk model Shide, Kotaro Takenaka, Katsuto Kitanaka, Akira Numata, Akihiko Kameda, Takuro Yamauchi, Takuji Inagaki, Atsushi Mizuno, Shohei Takami, Akiyoshi Ito, Shinichi Hagihara, Masao Usuki, Kensuke Maekawa, Takaaki Sunami, Kazutaka Ueda, Yasunori Tsutsui, Miyuki Ando, Miki Komatsu, Norio Ozawa, Keiya Kurokawa, Mineo Arai, Shunya Mitani, Kinuko Akashi, Koichi Shimoda, Kazuya Blood Cancer J Correspondence Nature Publishing Group UK 2023-07-19 /pmc/articles/PMC10354019/ /pubmed/37463903 http://dx.doi.org/10.1038/s41408-023-00869-9 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correspondence
Shide, Kotaro
Takenaka, Katsuto
Kitanaka, Akira
Numata, Akihiko
Kameda, Takuro
Yamauchi, Takuji
Inagaki, Atsushi
Mizuno, Shohei
Takami, Akiyoshi
Ito, Shinichi
Hagihara, Masao
Usuki, Kensuke
Maekawa, Takaaki
Sunami, Kazutaka
Ueda, Yasunori
Tsutsui, Miyuki
Ando, Miki
Komatsu, Norio
Ozawa, Keiya
Kurokawa, Mineo
Arai, Shunya
Mitani, Kinuko
Akashi, Koichi
Shimoda, Kazuya
Nationwide prospective survey of secondary myelofibrosis in Japan: superiority of DIPSS-plus to MYSEC-PM as a survival risk model
title Nationwide prospective survey of secondary myelofibrosis in Japan: superiority of DIPSS-plus to MYSEC-PM as a survival risk model
title_full Nationwide prospective survey of secondary myelofibrosis in Japan: superiority of DIPSS-plus to MYSEC-PM as a survival risk model
title_fullStr Nationwide prospective survey of secondary myelofibrosis in Japan: superiority of DIPSS-plus to MYSEC-PM as a survival risk model
title_full_unstemmed Nationwide prospective survey of secondary myelofibrosis in Japan: superiority of DIPSS-plus to MYSEC-PM as a survival risk model
title_short Nationwide prospective survey of secondary myelofibrosis in Japan: superiority of DIPSS-plus to MYSEC-PM as a survival risk model
title_sort nationwide prospective survey of secondary myelofibrosis in japan: superiority of dipss-plus to mysec-pm as a survival risk model
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10354019/
https://www.ncbi.nlm.nih.gov/pubmed/37463903
http://dx.doi.org/10.1038/s41408-023-00869-9
work_keys_str_mv AT shidekotaro nationwideprospectivesurveyofsecondarymyelofibrosisinjapansuperiorityofdipssplustomysecpmasasurvivalriskmodel
AT takenakakatsuto nationwideprospectivesurveyofsecondarymyelofibrosisinjapansuperiorityofdipssplustomysecpmasasurvivalriskmodel
AT kitanakaakira nationwideprospectivesurveyofsecondarymyelofibrosisinjapansuperiorityofdipssplustomysecpmasasurvivalriskmodel
AT numataakihiko nationwideprospectivesurveyofsecondarymyelofibrosisinjapansuperiorityofdipssplustomysecpmasasurvivalriskmodel
AT kamedatakuro nationwideprospectivesurveyofsecondarymyelofibrosisinjapansuperiorityofdipssplustomysecpmasasurvivalriskmodel
AT yamauchitakuji nationwideprospectivesurveyofsecondarymyelofibrosisinjapansuperiorityofdipssplustomysecpmasasurvivalriskmodel
AT inagakiatsushi nationwideprospectivesurveyofsecondarymyelofibrosisinjapansuperiorityofdipssplustomysecpmasasurvivalriskmodel
AT mizunoshohei nationwideprospectivesurveyofsecondarymyelofibrosisinjapansuperiorityofdipssplustomysecpmasasurvivalriskmodel
AT takamiakiyoshi nationwideprospectivesurveyofsecondarymyelofibrosisinjapansuperiorityofdipssplustomysecpmasasurvivalriskmodel
AT itoshinichi nationwideprospectivesurveyofsecondarymyelofibrosisinjapansuperiorityofdipssplustomysecpmasasurvivalriskmodel
AT hagiharamasao nationwideprospectivesurveyofsecondarymyelofibrosisinjapansuperiorityofdipssplustomysecpmasasurvivalriskmodel
AT usukikensuke nationwideprospectivesurveyofsecondarymyelofibrosisinjapansuperiorityofdipssplustomysecpmasasurvivalriskmodel
AT maekawatakaaki nationwideprospectivesurveyofsecondarymyelofibrosisinjapansuperiorityofdipssplustomysecpmasasurvivalriskmodel
AT sunamikazutaka nationwideprospectivesurveyofsecondarymyelofibrosisinjapansuperiorityofdipssplustomysecpmasasurvivalriskmodel
AT uedayasunori nationwideprospectivesurveyofsecondarymyelofibrosisinjapansuperiorityofdipssplustomysecpmasasurvivalriskmodel
AT tsutsuimiyuki nationwideprospectivesurveyofsecondarymyelofibrosisinjapansuperiorityofdipssplustomysecpmasasurvivalriskmodel
AT andomiki nationwideprospectivesurveyofsecondarymyelofibrosisinjapansuperiorityofdipssplustomysecpmasasurvivalriskmodel
AT komatsunorio nationwideprospectivesurveyofsecondarymyelofibrosisinjapansuperiorityofdipssplustomysecpmasasurvivalriskmodel
AT ozawakeiya nationwideprospectivesurveyofsecondarymyelofibrosisinjapansuperiorityofdipssplustomysecpmasasurvivalriskmodel
AT kurokawamineo nationwideprospectivesurveyofsecondarymyelofibrosisinjapansuperiorityofdipssplustomysecpmasasurvivalriskmodel
AT araishunya nationwideprospectivesurveyofsecondarymyelofibrosisinjapansuperiorityofdipssplustomysecpmasasurvivalriskmodel
AT mitanikinuko nationwideprospectivesurveyofsecondarymyelofibrosisinjapansuperiorityofdipssplustomysecpmasasurvivalriskmodel
AT akashikoichi nationwideprospectivesurveyofsecondarymyelofibrosisinjapansuperiorityofdipssplustomysecpmasasurvivalriskmodel
AT shimodakazuya nationwideprospectivesurveyofsecondarymyelofibrosisinjapansuperiorityofdipssplustomysecpmasasurvivalriskmodel